- Home
- ORKA vs DPG Comparison
ORKA vs DPG Comparison
Compare ORKA & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- DPG
- Stock Information
- Founded
- ORKA 2004
- DPG 2011
- Country
- ORKA United States
- DPG United States
- Employees
- ORKA N/A
- DPG N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DPG Trusts Except Educational Religious and Charitable
- Sector
- ORKA Health Care
- DPG Finance
- Exchange
- ORKA Nasdaq
- DPG Nasdaq
- Market Cap
- ORKA 429.4M
- DPG 457.8M
- IPO Year
- ORKA N/A
- DPG N/A
- Fundamental
- Price
- ORKA $10.09
- DPG $12.14
- Analyst Decision
- ORKA Strong Buy
- DPG
- Analyst Count
- ORKA 7
- DPG 0
- Target Price
- ORKA $39.67
- DPG N/A
- AVG Volume (30 Days)
- ORKA 394.0K
- DPG 150.1K
- Earning Date
- ORKA 05-15-2025
- DPG 01-01-0001
- Dividend Yield
- ORKA N/A
- DPG 9.09%
- EPS Growth
- ORKA N/A
- DPG N/A
- EPS
- ORKA N/A
- DPG N/A
- Revenue
- ORKA N/A
- DPG N/A
- Revenue This Year
- ORKA N/A
- DPG N/A
- Revenue Next Year
- ORKA N/A
- DPG N/A
- P/E Ratio
- ORKA N/A
- DPG N/A
- Revenue Growth
- ORKA N/A
- DPG N/A
- 52 Week Low
- ORKA $5.49
- DPG $7.90
- 52 Week High
- ORKA $53.88
- DPG $13.58
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- DPG 56.32
- Support Level
- ORKA N/A
- DPG $12.06
- Resistance Level
- ORKA N/A
- DPG $12.27
- Average True Range (ATR)
- ORKA 0.00
- DPG 0.41
- MACD
- ORKA 0.00
- DPG 0.07
- Stochastic Oscillator
- ORKA 0.00
- DPG 92.08
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting primarily from a high level of current income, with an emphasis on providing tax-advantaged dividend income.